INTERNATIONAL PATENT: THYMMUNE THERAPEUTICS, INC. FILES APPLICATION FOR "HYPOIMMUNE ENGINEERING FOR UNIVERSAL IPSC-DERIVED CELLS"

GENEVA, Dec. 10 -- THYMMUNE THERAPEUTICS, INC. (215 First Street, Suite 401Cambridge, Massachusetts 02142) filed a patent application (PCT/US2025/031023) for "HYPOIMMUNE ENGINEERING FOR UNIVERSAL IPSC-DERIVED CELLS" on May 27, 2025. With publication no. WO/2025/250531, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAMURAGLIA, Glenn Michael (c/o Thymmune Therapeutics, Inc.215 First Street, Suite 401Cambridge, Massachusetts 02142), DU, Qiumei (c/o Thymmune Therapeutics, Inc.215 First Street, Suite 401Cambridge, Massachuse...